APA (7th ed.) Citation

Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anit Singh, . . . Deepak Chandra Chilkoti. (2017). A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anit Singh, Anu Gupta, and Deepak Chandra Chilkoti. A Randomized, Open-label Clinical Trial to Evaluate Immunogenicity and Safety of an Indigenously Developed DTwP-Hib Tetravalent Combination Vaccine (Easyfour®-TT) with Quadrovax® in Indian Infants. Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

Lalitendu Mohanty, et al. A Randomized, Open-label Clinical Trial to Evaluate Immunogenicity and Safety of an Indigenously Developed DTwP-Hib Tetravalent Combination Vaccine (Easyfour®-TT) with Quadrovax® in Indian Infants. Taylor & Francis Group, 2017.